Best Fiber in Canada (2026)
October 30, 2026Inulin Eased Knee Pain and Boosted Grip: New Trial
November 1, 2026Quick Summary
A large UK trial tested high-dose EPA, a type of omega-3, around liver surgery for bowel cancer that had spread to the liver. It missed its main goal, yet five-year survival landed at 62% on EPA versus 45% on placebo. Experts call the result intriguing but preliminary, and say confirmatory trials are needed before anything changes in care. And no, this is not a reason to swallow handfuls of fish oil on your own.
Sometimes a trial fails its own test and still steals the show. That is what happened at the ESMO Congress 2026 in Madrid, where the phase 3 EMT2 trial was presented: the main outcome did not budge, but five-year survival landed 17 points apart. Here is the twist, untangled, before anyone runs to the supplement aisle.
| Topic | What the research shows |
|---|---|
| Trial | EMT2: randomised, double-blind, placebo-controlled phase 3 trial, ESMO Congress 2026 (Abstract LBA30) |
| Who took part | 418 UK patients having liver surgery with curative intent for colorectal cancer spread to the liver, at 13 centres |
| Dose | 4 grams purified EPA daily, from at least one day before surgery, planned for two to four years |
| Headline result | Estimated five-year survival: 62.0% with EPA versus 45.1% with placebo |
| The catch | Main goal, progression-free survival, nearly identical: 13.5 versus 12.9 months |
| Safety in the trial | Well tolerated: no excess side effects, bleeding, or irregular heartbeat versus placebo; no hit to quality of life |
| Status | Conference presentation, not yet peer-reviewed; confirmatory results needed |
The Trial That Missed Its Target and Still Made Headlines
Surgery that removes bowel cancer spread from the liver can offer long-term survival, but the cancer often comes back. Earlier lab work, observational studies, and a smaller phase 2 trial had hinted EPA might help here. EMT2 tested that properly: 418 patients were randomly assigned to 4 grams of purified EPA per day or a matching mineral oil placebo, starting just before surgery and continuing for years, even if the cancer progressed.
The trial’s main goal was progression-free survival, how long patients lived before their cancer got worse. On that measure, almost nothing separated the groups: a median of 13.5 months with EPA versus 12.9 months with placebo, a gap that was not statistically significant. By its own design, the trial missed.
Then came the secondary measure, overall survival, and the picture flipped. An estimated 62.0% on EPA were alive at five years, versus 45.1% on placebo, a roughly 32% lower risk of death (hazard ratio 0.68). The benefit held up among patients who stuck with treatment, and median overall survival had not been reached in the EPA group, versus 59.0 months with placebo. Lead author Professor Mark Hull of the University of Leeds said the benefit, if confirmed, would be clinically meaningful for a group in whom cancer frequently returns, adding that EPA was well tolerated alongside other cancer treatments.
Why Would Survival Improve If the Cancer Did Not Slow Down?
This is the puzzle, and the researchers admit they do not have the answer yet. Hull suggested the benefit might reflect how the body copes with cancer overall, including cachexia, the wasting syndrome behind weight loss, poor appetite, and fatigue. In other words, EPA may have helped patients withstand the disease and its treatment rather than directly shrinking tumours. A similar pattern has been seen with cancer immunotherapy, he noted.
Independent experts urged the same caution. Dr. Chiara Cremolini of the University of Pisa, who was not involved in the study, called the results definitely intriguing, but stressed that the mismatch requires careful interpretation. Progression-free survival is a less established stand-in for overall survival after liver-metastasis surgery than after early-stage bowel surgery, she noted, and extra data would help, including treatments patients received after recurrence and where the cancer spread. Her bottom line: confirmatory results are likely needed before routine use.
One reality check matters for Canadian readers. The 4-gram EMT2 dose was prescription-grade purified EPA given under medical supervision around major surgery, not a standard store fish oil capsule. In Canada, licensed fish oil products carry an eight-digit Natural Product Number (NPN), and Health Canada’s fish oil monograph sets the adult daily range for EPA plus DHA at 100 to 5,000 mg. Nobody facing cancer surgery should copy a trial dose on their own; that conversation belongs with the oncology team.
What Is Omega-3, and How Is It Supposed to Work?
Omega-3s are a family of polyunsaturated fats. Most research focuses on three: ALA (alpha-linolenic acid) from plant oils such as flaxseed, soybean, and canola, and EPA plus DHA from fatty fish and other seafood. ALA is the only one your body cannot make at all, hence essential, but conversion is the catch: your liver turns ALA into EPA and DHA only to a very limited extent, at rates reported under 15%. Eating EPA and DHA directly, from fish or supplements, is the practical way to raise your levels.
In the body, omega-3s become part of cell membranes, with DHA especially concentrated in the retina, brain, and sperm cells. They are also raw material for signalling molecules called eicosanoids, which act across the heart, blood vessels, lungs, immune system, and hormone systems. Researchers generally think EPA and DHA tip that signalling balance toward less inflammatory activity than competing omega-6 fats do. That is a mechanism, not a promise, and it does not mean a capsule will do any particular thing for you.
What Are the Side Effects of Omega-3?
For most people, common side effects are mild: unpleasant taste, bad breath, heartburn, nausea, stomach discomfort, diarrhoea, headache, and even odoriferous sweat. Taking capsules with food often helps, and enteric-coated options exist for fishy burps, though no form is magic.
More serious cautions kick in at higher doses and with certain medications. Very high intakes may increase bleeding time by reducing platelet aggregation, so people on blood thinners such as warfarin should discuss omega-3 use with their clinician and may need monitoring. Two large heart trials also found that 4 grams a day for several years slightly increased the risk of atrial fibrillation, an irregular heartbeat, in people with heart disease or at high risk. Interestingly, EMT2 found no excess atrial fibrillation or bleeding versus placebo in its surgical population, showing why dose, population, and context matter. Anyone pregnant, nursing, on medication, or managing a health condition should check with a healthcare professional first.
How Much Omega-3 Should You Take?
There is no single recommended amount for EPA and DHA. Authorities have set adequate intakes only for ALA: 1.6 grams a day for adult men and 1.1 grams a day for adult women. A typical fish oil supplement provides about 1,000 mg of fish oil with roughly 180 mg of EPA and 120 mg of DHA, though products vary widely. For comparison, 3 ounces of cooked farmed salmon provides about 1.8 grams of EPA plus DHA combined.
That puts the EMT2 dose in perspective: 4 grams of purified EPA daily for years is prescription territory, far above a standard capsule or a salmon dinner. European and US regulators have concluded that combined EPA and DHA up to about 5 grams a day appears safe when used as recommended, but safe is not the same as better. More is not better, especially given the irregular-heartbeat signal at 4 grams a day in heart trials. A high dose is a clinician conversation, not a self-experiment.
What Should You Look for on the Label?
First, look past the big number on the front. A bottle shouting 1,000 mg of fish oil may contain only a few hundred milligrams of EPA plus DHA, so check the actual amounts per serving. In Canada, look for a valid NPN, showing the product is licensed as a natural health product. Third-party testing is another plus: reputable products test for oxidation and marine contaminants, because rancid oil is both unpleasant and pointless.
Form matters less than marketers suggest. Fish oil comes as natural triglycerides, ethyl esters, re-esterified triglycerides, free fatty acids, or, in krill oil, phospholipids. The triglyceride, re-esterified, and free fatty acid forms are absorbed somewhat better than ethyl esters, but all forms raise blood EPA and DHA levels. Cod liver oil also supplies vitamins A and D, so factor those in. And if a label hides behind a proprietary blend without EPA and DHA amounts, put it back on the shelf.
References
- European Society for Medical Oncology. (2026, October 25). Omega-3 EPA linked to longer survival after surgery for colorectal cancer liver metastases. https://www.alphagalileo.org/en-gb/Item-Display/ItemId/279665
- The ASCO Post Staff. (2026, October 26). Omega-3 EPA linked to longer survival after surgery for colorectal cancer liver metastases. The ASCO Post. https://ascopost.com/news/october-2026/omega-3-epa-linked-to-longer-survival-after-surgery-for-colorectal-cancer-liver-metastases/
- Thompson, D. (2026, October 30). Omega-3s might improve survival in advanced cancer, trial finds. MedicineNet. https://www.medicinenet.com/omega_3s_may_improve_survival_in_advanced_cancer/news.htm
- National Institutes of Health, Office of Dietary Supplements. (n.d.). Omega-3 fatty acids: Fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
- Health Canada, Natural and Non-prescription Health Products Directorate. (2026, September 25). Fish oil [Monograph]. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/856
This article reports on recent health research and is for general information only — it isn’t medical advice and doesn’t replace your doctor, pharmacist, or another qualified professional. Study findings describe what researchers observed, not a promise of results, and nothing here claims any supplement can diagnose, treat, cure, or prevent a disease. These statements have not been evaluated by Health Canada. Check with a healthcare professional before starting any new supplement, especially if you’re pregnant, nursing, taking medication, or managing a health condition.
